![William H. Koster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William H. Koster
Président chez
eXIthera Pharmaceuticals, Inc.
Profil
William H.
Koster is currently the Chairman at eXIthera Pharmaceuticals, Inc. and the Vice Chairman at Ocuterra Therapeutics, Inc. He previously served as the Executive Chairman at Elicio Therapeutics, Inc. (Old), Director at Neurogen Corp., Director at Cadus Corp., Director at Phytomedics, Inc., Director at Robert Wood Johnson Health Care Corp., Director at Cadent Therapeutics, Inc., SVP-Science, Technology Strategy & Acquisition at Bristol Myers Squibb Co., Principal at Squibb Institute for Medical Research, and Strategic Advisor at Access BridgeGap Ventures.
He obtained his undergraduate degree from Colby College in 1966 and his doctorate degree from Tufts University in 1972.
Postes actifs de William H. Koster
| Sociétés | Poste | Début |
|---|---|---|
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures stroke prevention & antithrombosis drugs | Président | - |
Ocuterra Therapeutics, Inc.
 Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Manufactures drug products | Directeur/Membre du Conseil | - |
Anciens postes connus de William H. Koster
| Sociétés | Poste | Fin |
|---|---|---|
Access BridgeGap Ventures
 Access BridgeGap Ventures Investment ManagersFinance Access Bridgegap Ventures seeks to bridge the early-stage investment gap in the therapeutics space. The firm leverages their experience in start-up creation, technology commercialization and venture investing to fund young start-ups and create de novo spin-offs around potential high-impact technologies, many of which are still in academic research labs. | Corporate Officer/Principal | 10/10/2013 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Directeur Général | 04/02/2008 |
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Président | 09/01/2017 |
Squibb Institute for Medical Research | Corporate Officer/Principal | - |
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops, and manufactures botanical therapeutics | Directeur/Membre du Conseil | - |
Formation de William H. Koster
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Cadus Corp.
 Cadus Corp. BiotechnologyHealth Technology Provides drug research services | Health Technology |
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures stroke prevention & antithrombosis drugs | Health Technology |
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Discovers, develops, and manufactures botanical therapeutics | Health Technology |
Robert Wood Johnson Health Care Corp.
 Robert Wood Johnson Health Care Corp. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
Squibb Institute for Medical Research | |
Ocuterra Therapeutics, Inc.
Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Manufactures drug products | Retail Trade |
Access BridgeGap Ventures
Access BridgeGap Ventures Investment ManagersFinance Access Bridgegap Ventures seeks to bridge the early-stage investment gap in the therapeutics space. The firm leverages their experience in start-up creation, technology commercialization and venture investing to fund young start-ups and create de novo spin-offs around potential high-impact technologies, many of which are still in academic research labs. | Finance |
